Physician profile
Benjamin Giliberti
NPI 1427437763
$16,719.61
in general payments reported to CMS, 2019-2025
16 companies · $8,457 in 2025
The $8,457 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $196 · 2021: $2,465 · 2022: $3,517 · 2023: $734 · 2024: $1,352 · 2025: $8,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,375 · Food and Beverage: $2,022 · Travel and Lodging: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,375.00 |
| Food and Beverage | $2,021.94 |
| Travel and Lodging | $1,145.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $8,714.72 | 2021-2025 | Alif, Excelsiusgps Robotic Navigation System, Sable |
| Stryker Corporation | $1,837.94 | 2020-2021 | |
| Medtronic, INC. | $1,773.49 | 2022-2023 | Rialto Si Fusion System, Zevo Anterior Cervical Plate System |
| Alphatec Spine, INC | $1,255.97 | 2023-2025 | Other - Miscellaneous, Invictus Open, Identiti |
| Seapearl East, INC | $1,003.10 | 2024 | |
| Nuvasive, INC. | $793.48 | 2021-2022 | |
| Arthrex, INC. | $262.65 | 2024 | |
| Depuy Synthes Sales INC. | $221.82 | 2021-2023 | Teligen |
| Boston Scientific Corporation | $190.28 | 2022 | |
| Seaspine Orthopedics Corporation | $186.63 | 2021-2022 | |
| Augmedics INC. | $149.06 | 2021 | |
| Si-Bone, INC. | $144.49 | 2022 | |
| Medtronic USA, INC. | $104.08 | 2020 | |
| Kuros Biosciences USA, INC | $47.58 | 2021 | |
| Synergy Orthopedics, LLC | $17.32 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $17.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Giliberti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.